Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1442]

ASCO 2026: Updates in testicular, germ cell and rare genitourinary cancer

Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires...

ASCO 2026: Updates in testicular, germ cell and rare genitourinary cancer ( Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires, Argentina )

CLL TIM risk model predicts infection and treatment need in newly diagnosed...

Prof Carsten Niemann - Rigshospitalet, Copenhagen, Denmark

CLL TIM risk model predicts infection and treatment need in newly diagnosed chronic lymphocytic leukaemia ( Prof Carsten Niemann - Rigshospitalet, Copenhagen, Denmark )

Metronomic chemo plus nivolumab (TMC-I) improves survival in R/M head & neck...

Dr Minit Shah - Tata Memorial Centre, Mumbai, India

Metronomic chemo plus nivolumab (TMC-I) improves survival in R/M head & neck cancer vs platinum chemotherapy ( Dr Minit Shah - Tata Memorial Centre, Mumbai, India )

ASCO 2026: Comment: Multi-cancer earlier detection tests

Dr Marie Wood - UCHealth University of Colorado Hospital, Aurora, USA

ASCO 2026: Comment: Multi-cancer earlier detection tests ( Dr Marie Wood - UCHealth University of Colorado Hospital, Aurora, USA )

FMISO PET-guided radiation dose de-escalation maintains long-term outcomes in...

Dr Nancy Y. Lee - Memorial Sloan Kettering, New York, USA

FMISO PET-guided radiation dose de-escalation maintains long-term outcomes in HPV-associated oropharyngeal cancer ( Dr Nancy Y. Lee - Memorial Sloan Kettering, New York, USA )

ASCO 2026: Latest updates in mRCC

Dr Toni Choueiri, Prof Viktor Grünwald, Dr Martin Voss and Prof Jens Bedke

ASCO 2026: Latest updates in mRCC ( Dr Toni Choueiri, Prof Viktor Grünwald, Dr Martin Voss and Prof Jens Bedke )

Part 1: Why test?

Dr Elena Castro - Hospital Universitario 12 de Octubre, Madrid, Spain

Part 1: Why test? ( Dr Elena Castro - Hospital Universitario 12 de Octubre, Madrid, Spain )

Part 2: How to get biopsies for testing?

Dr Lynda Corrigan and Dr Stephen Finn

Part 2: How to get biopsies for testing? ( Dr Lynda Corrigan and Dr Stephen Finn )

Part 3: Managing testing efficiencies – How to optimise next generation...

Prof Eva Compérat - Medical University of Vienna, Vienna, Austria

Part 3: Managing testing efficiencies – How to optimise next generation sequencing and HRR testing ( Prof Eva Compérat - Medical University of Vienna, Vienna, Austria )

ctDNA predicts early treatment response in HPV-associated anal cancer

Dr Phebe Mawuena Afi Havor - Moffitt Cancer Center, Tampa, USA

ctDNA predicts early treatment response in HPV-associated anal cancer ( Dr Phebe Mawuena Afi Havor - Moffitt Cancer Center, Tampa, USA )

mCRPC treatment sequencing: Need for optimal therapy at the earliest opportunity

Prof Rana McKay - University of California San Diego, San Diego, USA

mCRPC treatment sequencing: Need for optimal therapy at the earliest opportunity ( Prof Rana McKay - University of California San Diego, San Diego, USA )

Low-dose CT screening reduces lung cancer mortality and improves survival in...

Dr Caichen Li - Guangzhou Medical University, Guangzhou, China

Low-dose CT screening reduces lung cancer mortality and improves survival in broad populations ( Dr Caichen Li - Guangzhou Medical University, Guangzhou, China )

More from ecancer